相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Forced vital capacity predicts the survival of interstitial lung disease in anti-MDA5 positive dermatomyositis: a multi-centre cohort study
Wanlong Wu et al.
RHEUMATOLOGY (2022)
GAP Score and CA-153 Associated with One-Year Mortality in Anti-MDA-5 Antibody-Positive Patients: A Real-World Experience
Chih-Wei Tseng et al.
JOURNAL OF CLINICAL MEDICINE (2021)
2020 guide for the diagnosis and treatment of interstitial lung disease associated with connective tissue disease
Yasuhiro Kondoh et al.
RESPIRATORY INVESTIGATION (2021)
Combination Therapy with Rituximab, Tofacitinib and Pirfenidone in a Patient with Rapid Progressive Interstitial Lung Disease (RP-ILD) Due to MDA5 Antibody-Associated Dermatomyositis: A Case Report
Tsai-Hung Yen et al.
MEDICINA-LITHUANIA (2021)
Tofacitinib in Amyopathic Dermatomyositis-Associated Interstitial Lung Disease
Zhiwei Chen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Tofacitinib for refractory interstitial lung diseases in anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis
Kazuhiro Kurasawa et al.
RHEUMATOLOGY (2018)